This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Activity 6: Next Steps for Patients with Sub-Optimal Glycemic Control
The sixth in a series addressing the challenges of managing diabetes, this activity features Dr. Neil Skolnik, a family physician, and Dr. Serena Cardillo, an endocrinologist, who describe practical strategies for individualizing and meeting glycemic goals in patients who have not achieved optimal glycemic control. The faculty reviews key recommendations from the 2012 American Diabetes Association (ADA) standards of care and considers factors that influence medication choice for specific patient groups. In particular, the faculty reviews the role of incretin mimetics in therapy. Finally, patient cases are used to illustrate key learning points from the program.
Learning Objectives
After completing this activity, the learner will be able to:
- Apply patient-specific criteria to initial selection and ongoing adjustments of the most effective treatment options for type 2 diabetes.
- Describe the various insulin options for patients whose blood glucose levels are not controlled on oral therapy.
- Describe the various oral agents available for the management of type 2 diabetes, together with their advantages and disadvantages, and describe strategies for adjusting therapy to optimize patient outcomes.
- Describe the current and potential role in therapy of new agents and delivery options.
Accessing the Activity
LearningLink is hosted by AAFP's technology partner MedEdArchitects. To access the activities (and to allow us to track learner progress through the program), you will need a LearningLink account. The only information required is your name, email address, and member status. Create a LearningLink account.
Begin Activity
Begin Activity
Acknowledgment of Support
This activity is supported by an independent educational grant from Sanofi US.
Diabetes Series
Activity 6: Sub-Optimal Glycemic Control
